ArticleFrontiers in pharmacology2026

Disitamab vedotin combined with PD-1 inhibitors for postoperative adjuvant therapy in upper tract urothelial carcinoma: a retrospective exploratory case series.

Yongbao Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.